Neofect

San Francisco, United States Founded: 2010 • Age: 16 yrs Listed
Smart rehabilitation devices for neurological injuries are developed by Neofect.

About Neofect

Neofect is a publicly listed company based in San Francisco (United States) founded in 2010 by Scott Kim. Smart rehabilitation devices for neurological injuries are developed by Neofect. It operates on a HealthTech and Direct-to-Consumer (D2C) model in Healthcare and Technology sectors. Neofect has raised $4 million across 2 funding rounds from investors including DSC Investment, SBI Investment Korea and Company K Partners. The company has 49 employees. Its website neofect.com draws about 17 thousand monthly visits. Neofect offers products and services including Smart Glove, Smart Board, Smart Pegboard, Cognition, and TeleRehab. Its focus areas include Medical Devices and Rehabilitation Equipment. Its competitors include HyperIce, KT Tape and Flint Rehab; 1 of its 3 listed competitors has raised funding.

Company details

Neofect is focused on creating clinically proven neurorehabilitation devices and services for upper extremity recovery. Solutions are offered in the healthcare sector, targeting stroke survivors and patients with motor impairments. Products like Smart Glove, Smart Board, and Smart Pegboard are designed to maximize arm and hand use through gamified training. Remote rehabilitation is supported via the TeleRehab platform. Partnerships with clinical institutions like Stanford Medical Center validate outcomes through trials. Operations span across 34 countries, serving over 3200 hospitals.

  • Headquarters San Francisco, United States
  • Employees 49
  • Founders Scott Kim
  • Stage Public
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website neofect.com/us
  • Social LinkedIn X Facebook Instagram
  • Legal Name Neofect Co.,Ltd
Key Metrics
  • Annual Revenue
    $11.11 M (USD)
    -7.07
    as on Dec 31, 2025
  • Net Profit
    -$8.52 M (USD)
    -1192.52
    as on Dec 31, 2025
  • EBITDA
    -$1.1 M (USD)
    -13.61
    as on Dec 31, 2025
  • Total Equity Funding
    $4M (USD)

    in 2 rounds

  • Latest Funding Round
    $8.55M (USD), Post-IPO

    Jul 2019

  • Investors
  • Employee Count
    49

Products & Services of Neofect

Neofect offers a comprehensive portfolio of products and services, including Smart Glove, Smart Board, Smart Pegboard, Cognition, and TeleRehab.

Smart Glove
Rehabilitation Device

Used for repetitive movement training in virtual environments.

Smart Board
Rehabilitation Device

Designed for unweighted proximal muscle strengthening exercises.

Smart Pegboard
Rehabilitation Device

Interactive tool for challenging dexterity, vision, and cognition.

Cognition
Rehabilitation Software

Computerized program for cognitive rehabilitation and training.

TeleRehab
Remote Rehabilitation Service

HIPAA-compliant platform for remote video conferencing rehabilitation.

Apps and channels of Neofect

Neofect publishes 1 mobile app with over 10K+ downloads.

Rehabit: brain recovery habits
Google Play Health & Fitness Everyone Free 10K+ downloads
Developer: Neofect USA
View on Google Play

Funding Insights of Neofect

Neofect has successfully raised a total of $4M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $8.55 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4M
  • Total Rounds 2
  • Last Round Post-IPO β€” $8.55M
  • First Round $4M

    (Mar 2015)

  • Investors Count 3

All 2 funding rounds of Neofect with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2019$8.55MPost-IPO––
Mar 2015$4MSeries B–SBI Investment Korea, DSC Investment
–
Valuation history

3 investors in total: 3 institutional.

Investors in Neofect

Neofect has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include DSC Investment, SBI Investment Korea and Company K Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital firm investing in tech startups
2006kpartners.co.krSeoul, South Korea
Sector-agnostic VC firm investing in geographies such as South Korea
1986sbik.co.krSeoul, South Korea
Early-stage venture capital is invested primarily in South Korean startups.
2012dscinvestment.comSeoul, South Korea
Premium access

Investor details for Neofect

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Neofect

4 people are tracked at Neofect (1 in leadership, 3 in team); the tracked headcount is 49.

NameRoleGroup
Scott Kim
Co-FounderLeadership
Justin Jeong
Accounting ManagerTeam
Kyle M.
Sales ManagerTeam
Rebecca Alter
Clinical ManagerTeam
Premium access

Complete people profiles for Neofect

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Neofect

Neofect is a publicly listed company on the KRX with ticker symbol 290660 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date15 Nov 2018
  • Listed onKRX: 290660
  • Listed entityNEOFECT CO.,LTD
  • Exchange sectorHealth technology
  • ISINKR7290660000
  • Share price1,154.00 KRW (-3.27% on the day) · 2026-10-14
  • Market capitalisation51,105,598,965.00 KRW
  • EPS (diluted, trailing year)-129.38 KRW
  • Volume (last session)330,791

Financials of Neofect

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202516.05B KRW-12.30B KRW-1.59B KRW
202417.27B KRW-951.4M KRW-1.40B KRW
202326.61B KRW-4.96B KRW411.4M KRW
202226.20B KRW-9.62B KRW-4.61B KRW
202123.16B KRW-5.04B KRW-4.52B KRW
Premium access

Detailed financial statements for Neofect

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Neofect

4 dated milestones of Neofect across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Neofect is founded.
  2. Funding First funding round of $4.0M.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding Latest funding round, Post-IPO, of $8.5M.

Competitors of Neofect

Neofect has 3 listed competitors in our database, 1 of them funded. They include HyperIce, KT Tape and Flint Rehab.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
hyperice.com2011Irvine, United States$48M
Internet first brand offering smart devices for physical fitness
kttape.com2009American Fork, United States110
Manufacturer of kinesiology tape and related recovery products. It offers a variety of tapes designed for different needs and activity levels, including options for sensitive skin and specific areas of the body. The product line also includes supporting items such as ice sleeves, pain relief gels, and blister prevention products. The company provides educational resources on proper application techniques and offers a mobile application for further support. The focus is on providing solutions for pain relief, muscle support, and recovery from injuries.
flintrehab.com2011Irvine, United States9
Developer of stroke rehabilitation systems
Premium access

Detailed competitors of Neofect

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Neofect

The website of Neofect (neofect.com) receives about 17.4K visits a month.

  • Monthly visits
    17.4K

    ▲ 22.4% vs previous month

Similar websites

Websites whose visitors overlap most with Neofect. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
soksiwon.kr
soksiwon.kr
100%
#1,554,815–
syrebo.com
syrebo.com
98%
#2,213,175–
brooksrehab.org
98%
#696,703View details
healthcare-in-europe.com
healthcare-in-europe.com
98%
#222,447–
novavision.com
75%
3.1K#3,638,555View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 12 similar websites and full traffic analytics for Neofect

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 12 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Neofect (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Neofect

Premium access

Complete news archive for Neofect

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neofect

Neofect was founded in 2010 and raised its 1st funding round 5 years after it was founded.

Neofect is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Neofect is a funded company, having raised a total of $4M across 2 funding rounds to date. The company's 1st funding round was a Series B of $4M, raised on Mar 2015.

Neofect has 49 employees.

Annual revenue of Neofect is $11.11M as on Dec 31, 2025.

Neofect is focused on creating clinically proven neurorehabilitation devices and services for upper extremity recovery. Solutions are offered in the healthcare sector, targeting stroke survivors and patients with motor impairments. Products like Smart Glove, Smart Board, and Smart Pegboard are designed to maximize arm and hand use through gamified training. Remote rehabilitation is supported via the TeleRehab platform. Partnerships with clinical institutions like Stanford Medical Center validate outcomes through trials. Operations span across 34 countries, serving over 3200 hospitals.

Neofect's top competitors include HyperIce, KT Tape and Flint Rehab.

Neofect offers Smart Glove, Smart Board, Smart Pegboard, Cognition, and TeleRehab.

Yes, Neofect is publicly traded on KRX under the ticker symbol 290660.

Neofect has 3 investors. Key investors include DSC Investment, SBI Investment Korea, and Company K Partners.

Neofect operates through Neofect.

Yes. Neofect publishes Rehabit: brain recovery habits, with over 10,000 downloads.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available